September is World Alzheimer’s Month, and in recognition, it’s a good time to take stock of where things stand. In general, we continue to face a world where there are few effective treatments (and lots of continued controversy about Aduhelm, the recently FDA-approved treatment for Alzheimer’s, which many insurers and…